Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,788.00
-67.50 (-3.64%)
Oct 23, 2026, 12:50 PM IST
Wockhardt Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 290,536 | 191,042 | 231,444 | 89,847 | 22,175 | 37,972 | |
Market Cap Growth | 30.25% | -17.46% | 157.60% | 305.17% | -41.60% | -17.21% |
Enterprise Value | 310,136 | 208,912 | 255,474 | 114,507 | 44,975 | 66,283 |
Last Close Price | 1855.50 | 1175.70 | 1424.40 | 585.70 | 153.90 | 263.60 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 70.99 | 89.69 | - | - | - | - |
Forward PE | - | 38.49 | 38.49 | 38.49 | 38.49 | 38.49 |
PS Ratio | 8.25 | 5.52 | 7.61 | 3.18 | 0.84 | 1.18 |
PB Ratio | 5.71 | 3.62 | 4.97 | 2.45 | 0.61 | 0.90 |
P/TBV Ratio | 15.13 | 9.59 | 13.23 | 8.99 | 1.94 | 2.07 |
P/FCF Ratio | 118.70 | 75.21 | - | 56.15 | 19.98 | 12.87 |
P/OCF Ratio | 77.31 | 48.99 | - | 41.03 | 14.49 | 9.19 |
PEG Ratio | - | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 8.79 | 6.03 | 8.40 | 4.05 | 1.69 | 2.05 |
EV/EBITDA Ratio | 39.83 | 31.75 | 69.61 | 82.98 | 107.08 | 29.33 |
EV/EBIT Ratio | 55.36 | 42.46 | 121.65 | - | - | 129.97 |
EV/FCF Ratio | 126.42 | 82.25 | - | 71.57 | 40.52 | 22.47 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.42 | 0.42 | 0.43 | 0.64 | 0.60 | 0.52 |
Debt / EBITDA Ratio | 2.77 | 3.12 | 4.77 | 11.96 | 21.00 | 7.61 |
Debt / FCF Ratio | - | 8.79 | - | 14.73 | 19.68 | 7.45 |
Net Debt / Equity Ratio | 0.29 | 0.29 | 0.31 | 0.50 | 0.56 | 0.43 |
Net Debt / EBITDA Ratio | 2.08 | 2.36 | 3.91 | 13.28 | 49.24 | 8.04 |
Net Debt / FCF Ratio | - | 6.11 | -12.35 | 11.46 | 18.63 | 6.16 |
Asset Turnover | - | 0.41 | 0.39 | 0.37 | 0.33 | 0.40 |
Inventory Turnover | - | 1.50 | 1.76 | 1.89 | 1.64 | 1.72 |
Quick Ratio | - | 0.78 | 0.61 | 0.41 | 0.27 | 0.42 |
Current Ratio | - | 1.66 | 1.26 | 0.78 | 0.64 | 0.81 |
Return on Equity (ROE) | - | 4.00% | -1.37% | -12.89% | -15.79% | -7.01% |
Return on Assets (ROA) | - | 3.67% | 1.66% | -0.17% | -1.12% | 0.40% |
Return on Invested Capital (ROIC) | 7.59% | 6.37% | 3.62% | -0.37% | -2.43% | 0.84% |
Return on Capital Employed (ROCE) | - | 7.00% | 3.40% | -0.40% | -3.40% | 1.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.41% | 1.11% | -0.20% | -5.15% | -25.21% | -6.43% |
FCF Yield | 0.84% | 1.33% | -0.50% | 1.78% | 5.01% | 7.77% |
Buyback Yield / Dilution | -1.03% | -3.66% | -8.77% | -0.13% | -19.50% | -0.35% |
Total Shareholder Return | -1.03% | -3.66% | -8.77% | -0.13% | -19.50% | -0.35% |